Acasti Pharma Inc.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
0/10
|
0 | 48.77 | -100% | -0.1885 | -100% |
| P/S |
|
26141.39 | 33.77 | 77319.11% |
|
|
| P/BV |
|
0.5263 | 4.83 | -89.1% |
|
|
| P/FCF |
|
0 | 61 | -100% |
|
|
| Ev/Ebitda |
|
-0.8397 | -22.17 | -96.21% |
|
|
| Ev/S |
|
948.93 | 22.57 | 4103.88% |
|
|
| Ev/FCF |
|
-0.7681 | 68.76 | -101.12% |
|
|
| E/P |
|
0 | 0.0178 | -100% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
-153761.54 | 4.97 | -3092606.01% | -36702.3 | +318.94% |
| ROE |
|
-22.95 | 9.61 | -338.75% |
|
|
| ROA |
|
-19.5 | 0.3443 | -5763.7% |
|
|
| ROIC |
|
0 | 7.63 | -100% |
|
|
| ROS |
|
-128530 | -25.17 | 510545.25% |
|
|
| ROCE |
|
-15.8 | 15.45 | -202.24% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-0.0318 | -3.68 | -99.14% | -0.0113 | +181.98% |
| Nеt Debt/Ebitda |
|
2.04 | -3.44 | -159.22% |
|
|
| Debt/Ratio |
|
0.0049 | 0.1986 | -97.53% |
|
|
| Debt/Equity |
|
1.42 | 1.66 | -14.34% |
|
|
| Debt/Net Income |
|
-0.0279 | 10.32 | -100.27% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 0.541 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 0.7368 | -100% | ||
| DSI |
|
0 | 0.2256 | -100% |
|
|
| Average dividend growth |
|
0 | 0.9598 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 0.4928 | -100% |
|
|
| Average percentage for payments |
|
0 | 43.56 | -100% |
|
|
| Difference from average difference in sector |
|
-0.541 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
0/10
|
-97.69 | -57.64 | 69.48% | ||
| Growth impulse Ebitda in 5 years |
|
-27.09 | -90.94 | -70.21% | ||
| Growth impulse Net Income in 5 years |
|
-29.77 | -97.8 | -69.56% | ||
| Growth impulse FCF in 5 years |
|
-25.12 | -108.72 | -76.89% | ||
| Growth impulse EPS in 5 years |
|
-87.03 | -142.05 | -38.73% |
IP Score
2.56/10
